Global Companion Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts

Publisher Name :
Date: 01-Oct-2017
No. of pages: 248
Inquire Before Buying

The Global Companion Diagnostics Partnering 2010-2017 report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in companion diagnostics partnering deals

Companion diagnostics partnering agreement structure

Companion diagnostics partnering contract documents

Top companion diagnostics deals by value

Most active companion diagnostics dealmakers

The report provides a detailed understanding and analysis of how and why companies enter Companion Diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of the latest Companion Diagnostics agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Companion Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Companion Diagnostics partnering deals.

The report presents financial deal term values for Companion Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Companion Diagnostics partnering field; both the leading deal values and most active Companion Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 350 online deal records of actual Companion Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Companion Diagnostics dealmaking.

Chapter 1 provides an introduction to the report, whilst

Chapter 2 provides an overview of the trends in Companion Diagnostics dealmaking since 2010, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Companion Diagnostics deals since 2010. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Companion Diagnostics dealmaking with a brief summary followed by a comprehensive listing of Companion Diagnostics deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Companion Diagnostics partnering deals signed and announced since Jan 2010, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Companion Diagnostics partnering deals signed and announced since Jan 2010. The

Chapter is organized by specific Companion Diagnostics technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Companion Diagnostics partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Companion Diagnostics partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Companion Diagnostics technologies and products.

Key benefits

Global Companion Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts provides the reader with the following key benefits:

In-depth understanding of Companion Diagnostics deal trends since 2010

Access to headline, upfront, milestone and royalty data

Analysis of the structure of Companion Diagnostics agreements with numerous real life case studies

Detailed access to actual Companion Diagnostics contracts entered into by leading biopharma companies

Identify most active Companion Diagnostics dealmakers since 2010

Insight into terms included in a Companion Diagnostics partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Companion Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Companion Diagnostics trends and structure of deals entered into by leading companies worldwide.

Companion Diagnostics Partnering Terms and Agreements includes:

Trends in Companion Diagnostics dealmaking in the biopharma industry since 2010

Analysis of Companion Diagnostics deal structure

Access to headline, upfront, milestone and royalty data

Case studies of real-life Companion Diagnostics deals

Access to Companion Diagnostics contract documents

Leading Companion Diagnostics deals by value since 2010

Most active Companion Diagnostics dealmakers since 2010

In Global Companion Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts, the available deals are listed by:

Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Companion Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 350 Companion Diagnostics deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How aresalesand payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Companion Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Companion Diagnostics dealmaking
2.1. Introduction
2.2. Companion Diagnostics partnering over the years
2.3. Most active Companion Diagnostics dealmakers
2.4. Companion Diagnostics partnering by deal type
2.5. Companion Diagnostics partnering by therapy area
2.6. Deal terms for Companion Diagnostics partnering
2.6.1 Companion Diagnostics partnering headline values
2.6.2 Companion Diagnostics deal upfront payments7
2.6.3 Companion Diagnostics deal milestone payments
2.6.4 Companion Diagnostics royalty rates

Chapter 3 - Leading Companion Diagnostics deals
3.1. Introduction
3.2. Top Companion Diagnostics deals by value

Chapter 4 - Most active Companion Diagnostics dealmakers
4.1. Introduction
4.2. Most active Companion Diagnostics dealmakers
4.3. Most active Companion Diagnostics partnering company profiles

Chapter 5 - Companion Diagnostics contracts dealmaking directory
5.1. Introduction
5.2. Companion Diagnostics contracts dealmaking directory

Chapter 6 - Companion Diagnostics dealmaking by technology type

Chapter 7 - Partnering resource center
7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 - Companion Diagnostics deals by company A-Z

Appendix 2 - Companion Diagnostics deals by stage of development

Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation

Appendix 3 - Companion Diagnostics deals by deal type

Asset purchase
Assignment
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Litigation
Manufacturing
Marketing
Material transfer
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Technology transfer
Termination
Warranty

Appendix 4 - Companion Diagnostics deals by therapy area

Appendix 5 -Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering

List of Figures

Figure 1: Companion Diagnostics partnering since 2010
Figure 2: Active Companion Diagnostics dealmaking activity since 2010
Figure 3: Companion Diagnostics partnering by deal type since 2010
Figure 4: Companion Diagnostics partnering by disease type since 2010
Figure 5: Companion Diagnostics deals with a headline value
Figure 6: Companion Diagnostics deals with an upfront value
Figure 7: Companion Diagnostics deals with a milestone value
Figure 8: Companion Diagnostics deals with a royalty rate value
Figure 9: Top Companion Diagnostics deals by value since 2010
Figure 10: Most active Companion Diagnostics dealmakers since 2010
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events
  • Global Toxicology Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 18-Sep-2018        Price: US 3480 Onwards        Pages: 121
    The toxicology testing market includes safety assessment of chemicals, drugs, cosmetic products, food additives, etc, without using animals as test models. This testing is performed on advance cell and tissue models to determine safety by studying the potential of the test substances to cause toxicity, such as genotoxicity, skin irritation and sensitization, cytotoxicity, ocular toxicity, organ toxicity, phototoxicity, dermal toxicity, and other toxicities. Scope of the Report:......
  • Global Antigen Skin Test Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Sep-2018        Price: US 3480 Onwards        Pages: 106
    Antigen Skin Test is mainly performed so that the immune systems can be tested against the antigens. Scope of the Report: This report focuses on the Antigen Skin Test in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Antigen Skin Test is expected to grow at a CAGR of roughly xx......
  • Global Clostridium Diagnostics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Sep-2018        Price: US 3480 Onwards        Pages: 137
    Clostridium is a gram-positive bacteria that belongs to the Firmicutes phylum. There are multiple species of Clostridium — Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, and Clostridium sordellii, which are responsible for numerous infections. Clostridium tetani is responsible for tetanus, Clostridium botulinum causes botulism, Clostridium perfringes leads to gas gangrene, Clostridium sortellii causes pneumonia, endocarditis, arthritis, peritonitis, an......
  • 2018-2023 Global Food Diagnostics Systems Consumption Market Report
    Published: 10-Sep-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Food Diagnostics Systems market for 2018-2023. The food diagnostics market was sub-segmented into diagnostic systems and consumables. The emerging markets with increasing demand for food testing are estimated to generate potential opportunities in the market. Over the next five years, LPI(LP Information) projects that Food Diagnostics Systems ......
  • Global Prenatal Screening Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Prenatal Screening Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understa......
  • Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing
    Published: 31-Aug-2018        Price: US 5500 Onwards        Pages: 211
    Report Scope: The study scope includes clinical therapies using gene editing, gene therapy, genetically modified cell therapy (chimeric antigen receptor T-cells, or CAR T-cells) or RNA therapy platforms. Delivery technologies covered include AAV, adenovirus, lentivirus, retrovirus, other viral and nonviral. Disease areas covered include cardiology, oncology, ophthalmology, hematology, musculoskeletal, neurology, rare diseases and others. Therapies that are already commercialized or ......
  • Global Microbiological Testing of Water Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 28-Aug-2018        Price: US 3480 Onwards        Pages: 128
    The market is driven by factors such as the requirement of advanced equipment with less turnaround time and active involvement & funding by government authorities for the development of advanced technology for microbial water quality analysis. Scope of the Report: This report focuses on the Microbiological Testing of Water in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufa......
  • Global Microbiological Testing of Water Market Professional Survey Report 2018
    Published: 27-Aug-2018        Price: US 3500 Onwards        Pages: 116
    This report studies the global Microbiological Testing of Water market status and forecast, categorizes the global Microbiological Testing of Water market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The market is driven by factors such as the requirement of advanced equipment wit......
  • Next Generation Sequencing for Non-invasive Prenatal Testing: Global Insights
    Published: 24-Aug-2018        Price: US 5500 Onwards        Pages: 189
    Report Scope: The scope of the report includes NIPT methods, applications, patents and companies. The markets for NGS-based NIPT are given for the years 2017, 2018 and 2023. This report reviews the main sequencing technologies and provides detailed discussion on next generation sequencing and its applications in different fields. The main focus of the study is NIPT. The market dynamics such as drivers and restraints for both NGS and NIPT market have been discussed in t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs